{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:30:48Z","timestamp":1786984248752,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ajo.2017.10.027","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T23:17:30Z","timestamp":1509751050000},"page":"xxiii-xxxii","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Evolving Concepts in the Management of Retinopathy of Prematurity"],"prefix":"10.1016","volume":"186","author":[{"suffix":"Jr.","given":"Paul","family":"Sternberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia K.","family":"Durrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2017.10.027_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9394(42)92088-9","article-title":"Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens","volume":"25","author":"Terry","year":"1942","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2017.10.027_bib2","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/0002-9394(53)91779-6","article-title":"Oxygen studies in retrolental fibroplasia","volume":"36","author":"Patz","year":"1953","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2017.10.027_bib3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9394(52)91140-9","article-title":"Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations","volume":"35","author":"Patz","year":"1952","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2017.10.027_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/bjo.37.9.513","article-title":"Role of oxygen in the genesis of retrolental fibroplasia; a preliminary report","volume":"37","author":"Ashton","year":"1953","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2017.10.027_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ajo.2009.04.018","article-title":"Incidence of Retinopathy of Prematurity in the United States: 1997 through 2005","volume":"148","author":"Lad","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2017.10.027_bib6","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archopht.1984.01040030908011","article-title":"An international classification of retinopathy of prematurity","volume":"102","year":"1984","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2017.10.027_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1542\/peds.81.5.697","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results","volume":"81","year":"1988","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ajo.2017.10.027_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archopht.123.3.311","article-title":"15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity","volume":"123","author":"Palmer","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2017.10.027_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(14)77029-1","article-title":"Argon laser photocoagulation for advanced retinopathy of prematurity","volume":"110","author":"Landers","year":"1990","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2017.10.027_bib10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0002-9394(14)74488-5","article-title":"Diode laser photocoagulation for prethreshold, posterior retinopathy of prematurity","volume":"114","author":"Fleming","year":"1992","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2017.10.027_bib11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0161-6420(91)32247-4","article-title":"Laser photocoagulation for stage 3+ retinopathy of prematurity","volume":"98","author":"McNamara","year":"1991","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2017.10.027_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archopht.1994.01090140028007","article-title":"The Laser ROP Study Group. Laser therapy for retinopathy of prematurity","volume":"112","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2017.10.027_bib13","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2017.10.027_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archophthalmol.2010.72","article-title":"Final visual acuity results in the early treatment for retinopathy of prematurity study","volume":"128","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"22","key":"10.1016\/j.ajo.2017.10.027_bib15","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJM199805283382202","article-title":"Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group","volume":"338","author":"Reynolds","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajo.2017.10.027_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1542\/peds.79.4.489","article-title":"Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial","volume":"79","author":"Phelps","year":"1987","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.ajo.2017.10.027_bib17","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1001\/archophthalmol.2009.322","article-title":"Clinical presentation and genetic correlation of patients with mutations affecting the FZD4 gene","volume":"127","author":"Drenser","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2017.10.027_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3928\/23258160-20151214-02","article-title":"Retinopathy of prematurity versus familial exudative vitreoretinopathy: report on clinical and angiographic findings","volume":"47","author":"John","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"10.1016\/j.ajo.2017.10.027_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3928\/15428877-20070501-09","article-title":"Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity","volume":"38","author":"Travassos","year":"2007","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"6","key":"10.1016\/j.ajo.2017.10.027_bib20","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ajo.2017.10.027_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ajo.2017.10.027_bib22","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ophtha.2014.05.015","article-title":"Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings","volume":"121","author":"Lepore","year":"2014","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2017.10.027_bib23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","article-title":"Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity","volume":"122","author":"Hwang","year":"2015","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2017.10.027_bib24","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1111\/aos.13008","article-title":"Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity","volume":"94","author":"Karkhaneh","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2017.10.027_bib25","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.ophtha.2017.03.018","article-title":"Ranibizumab injection as primary treatment in patients with retinopathy of prematurity: anatomic outcomes and influencing factors","volume":"124","author":"Huang","year":"2017","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2017.10.027_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/IAE.0000000000001125","article-title":"Outcomes after laser versus combined laser and bevacizumab treatment for type 1 retinopathy of prematurity in zone I","volume":"37","author":"Yoon","year":"2017","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ajo.2017.10.027_bib27","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/IAE.0000000000001241","article-title":"Comparison of intravitreal injection of ranibizumab versus laser therapy for zone II treatment-requiring retinopathy of prematurity","volume":"37","author":"Zhang","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2017.10.027_bib28","first-page":"532","article-title":"Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California)","volume":"12","author":"Lutty","year":"2006","journal-title":"Mol Vis"},{"issue":"11","key":"10.1016\/j.ajo.2017.10.027_bib29","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00417-007-0661-y","article-title":"Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity","volume":"245","author":"Chung","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2017.10.027_bib30","doi-asserted-by":"crossref","first-page":"27082","DOI":"10.1038\/srep27082","article-title":"Risk of recurrence of retinopathy of prematurity after initial intravitreal ranibizumab therapy","volume":"6","author":"Chan","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajo.2017.10.027_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2017.10.027_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00417-015-2996-0","article-title":"Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab","volume":"254","author":"Zhou","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2017.10.027_bib33","doi-asserted-by":"crossref","first-page":"e20153218","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ajo.2017.10.027_bib34","doi-asserted-by":"crossref","first-page":"e0148019","DOI":"10.1371\/journal.pone.0148019","article-title":"Neurodevelopmental outcomes in infants with retinopathy of prematurity and bevacizumab treatment","volume":"11","author":"Lien","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ajo.2017.10.027_bib35","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ophtha.2016.04.028","article-title":"Clinical management of recurrent retinopathy of prematurity after intravitreal bevacizumab monotherapy","volume":"123","author":"Mintz-Hittner","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2017.10.027_bib36","unstructured":"Yonekawa Y, Wu W-C, Nitulescu CE, et\u00a0al. Progressive retinal detachment in infants with retinopathy of prematurity treated with intravitreal bevacizumab or ranibizumab. Retina. https:\/\/doi.org\/10.1097\/IAE.0000000000001685.2017.05.03."},{"issue":"3","key":"10.1016\/j.ajo.2017.10.027_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3928\/23258160-20170301-10","article-title":"Reactivation of retinopathy of prematurity three years after treatment with bevacizumab","volume":"48","author":"Hajrasouliha","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"6","key":"10.1016\/j.ajo.2017.10.027_bib38","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0161-6420(90)32506-X","article-title":"Scleral buckling in stages 4B and 5 retinopathy of prematurity","volume":"97","author":"Greven","year":"1990","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2017.10.027_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0161-6420(94)31362-5","article-title":"Scleral buckling for retinopathy of prematurity","volume":"101","author":"Trese","year":"1994","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2017.10.027_bib40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/ICB.0000000000000221","article-title":"Concurrent scleral buckle and intravitreal bevacizumab for advanced retinopathy of prematurity-related retinal detachment","volume":"10","author":"Shah","year":"2016","journal-title":"Retin Cases Brief Rep"},{"issue":"11","key":"10.1016\/j.ajo.2017.10.027_bib41","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0161-6420(01)00809-0","article-title":"Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments","volume":"108","author":"Capone","year":"2001","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2017.10.027_bib42","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.ophtha.2004.06.021","article-title":"Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity","volume":"111","author":"Prenner","year":"2004","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2017.10.027_bib43","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ophtha.2014.11.004","article-title":"Long-term outcomes on lens clarity after lens-sparing vitrectomy for retinopathy of prematurity","volume":"122","author":"Nudleman","year":"2015","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2017.10.027_bib44","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/IAE.0b013e3181610f97","article-title":"Three-year anatomic and visual outcomes after vitrectomy for stage 4B retinopathy of prematurity","volume":"28","author":"Rayes El","year":"2008","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.ajo.2017.10.027_bib45","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/bjophthalmol-2016-309198","article-title":"Long-term functional results following vitrectomy for advanced retinopathy of prematurity","volume":"101","author":"Karacorlu","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2017.10.027_bib46","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/01.iae.0000244274.95963.1e","article-title":"Anatomical success rate after primary three-port lens-sparing vitrectomy in stage 5 retinopathy of prematurity","volume":"26","author":"Lakhanpal","year":"2006","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.ajo.2017.10.027_bib47","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archophthalmol.2012.1890","article-title":"Improving preterm ophthalmologic care in the era of accountable care organizations","volume":"130","author":"Wang","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2017.10.027_bib48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcjo.2014.11.005","article-title":"SUNDROP: six years of screening for retinopathy of prematurity with telemedicine","volume":"50","author":"Wang","year":"2015","journal-title":"Can J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2017.10.027_bib49","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.ophtha.2016.04.035","article-title":"Diagnostic discrepancies in retinopathy of prematurity classification","volume":"123","author":"Campbell","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2017.10.027_bib50","unstructured":"AAP, AAOPOS, AAO Hoskins Center for Quality Eye Care. Screening Examination of Premature Infants for Retinopathy of Prematurity 2013. American Academy of Ophthalmology, San Francisco."},{"issue":"5","key":"10.1016\/j.ajo.2017.10.027_bib51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaapos.2016.06.007","article-title":"Timely implementation of a retinopathy of prematurity telemedicine system","volume":"20","author":"Quinn","year":"2016","journal-title":"J AAPOS"},{"issue":"4","key":"10.1016\/j.ajo.2017.10.027_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archopht.126.4.493","article-title":"Cost-utility analysis of telemedicine and ophthalmoscopy for retinopathy of prematurity management","volume":"126","author":"Jackson","year":"2008","journal-title":"Arch Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939417304580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939417304580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:36:50Z","timestamp":1757597810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939417304580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":52,"alternative-id":["S0002939417304580"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2017.10.027","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving Concepts in the Management of Retinopathy of Prematurity","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2017.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}